Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 469

1.

Translating Research into Agile Development (TRIAD): Development of Electronic Health Record Tools for Primary Care Settings.

Clark KD, Woodson TT, Holden RJ, Gunn R, Cohen DJ.

Methods Inf Med. 2019 Jun;58(1):1-8. doi: 10.1055/s-0039-1692464. Epub 2019 Jul 5.

PMID:
31277082
2.

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M.

Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.

PMID:
31229470
3.

Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease.

Pagano G, Niccolini F, Wilson H, Yousaf T, Khan NL, Martino D, Plisson C, Gunn RN, Rabiner EA, Piccini P, Foltynie T, Politis M.

Mov Disord. 2019 Jun 3. doi: 10.1002/mds.27733. [Epub ahead of print]

PMID:
31158314
4.

Imaging chemotherapy induced acute cardiotoxicity with 18F-labelled lipophilic cations.

McCluskey S, Haslop A, Coello C, Gunn R, Tate E, Southworth R, Plisson C, Long NJ, Wells L.

J Nucl Med. 2019 May 30. pii: jnumed.119.226787. doi: 10.2967/jnumed.119.226787. [Epub ahead of print]

PMID:
31147403
5.

Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Martín-Bastida A, Lao-Kaim NP, Roussakis AA, Searle GE, Xing Y, Gunn RN, Schwarz ST, Barker RA, Auer DP, Piccini P.

Brain. 2019 May 5. pii: awz120. doi: 10.1093/brain/awz120. [Epub ahead of print]

PMID:
31056699
6.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

7.

A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices.

Carney PA, Hatch B, Stock I, Dickinson C, Davis M, Larsen R, Valenzuela S, Marino M, Darden PM, Gunn R, Ferrara L, Fagnan LJ.

Implement Sci. 2019 Mar 14;14(1):30. doi: 10.1186/s13012-019-0871-9.

8.

Aligning systems science and community-based participatory research: A case example of the Community Health Advocacy and Research Alliance (CHARA).

Davis MM, Lindberg P, Cross S, Lowe S, Gunn R, Dillon K.

J Clin Transl Sci. 2018 Oct;2(5):280-288. doi: 10.1017/cts.2018.334.

9.

The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease.

Wilson H, Pagano G, Niccolini F, Muhlert N, Mehta MA, Searle G, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Parkinsonism Relat Disord. 2019 Feb 22. pii: S1353-8020(19)30073-2. doi: 10.1016/j.parkreldis.2019.02.027. [Epub ahead of print]

PMID:
30824285
10.

Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R.

Mol Imaging Biol. 2019 Feb 22. doi: 10.1007/s11307-019-01323-8. [Epub ahead of print]

PMID:
30796709
11.

The effects of fatigue on the running profile of elite team sport athletes. A systematic review and meta-analysis.

Garrett JM, Gunn R, Eston RG, Jakeman J, Burgess DJ, Norton K.

J Sports Med Phys Fitness. 2019 Feb 12. doi: 10.23736/S0022-4707.19.09356-3. [Epub ahead of print]

PMID:
30758168
12.

Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Plavén-Sigray P, Schain M, Zanderigo F; Karolinska [(11)C]PBR28 study group, Rabiner EA, Gunn RN, Ogden RT, Cervenka S.

Neuroimage. 2019 Mar;188:102-110. doi: 10.1016/j.neuroimage.2018.11.020. Epub 2018 Nov 27.

13.

Clinical Workflows and the Associated Tasks and Behaviors to Support Delivery of Integrated Behavioral Health and Primary Care.

Davis MM, Gunn R, Cifuentes M, Khatri P, Hall J, Gilchrist E, Peek CJ, Klowden M, Lazarus JA, Miller BF, Cohen DJ.

J Ambul Care Manage. 2019 Jan/Mar;42(1):51-65. doi: 10.1097/JAC.0000000000000257.

PMID:
30499901
14.

Designing health information technology tools for behavioral health clinicians integrated within a primary care team.

Woodson TT, Gunn R, Clark KD, Balasubramanian BA, Jetelina KK, Muller B, Miller BF, Burdick TE, Cohen DJ.

J Innov Health Inform. 2018 Oct 31;25(3):158-168. doi: 10.14236/jhi.v25i3.998.

15.

Marijuana use is associated with alcohol use and consequences across the first 2 years of college.

Gunn RL, Norris AL, Sokolovsky A, Micalizzi L, Merrill JE, Barnett NP.

Psychol Addict Behav. 2018 Dec;32(8):885-894. doi: 10.1037/adb0000416. Epub 2018 Oct 25.

PMID:
30359046
16.

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Dec;33(12):1961-1965. doi: 10.1002/mds.27523. Epub 2018 Oct 21.

PMID:
30345538
17.

Predictors of Effective Working Memory Training in Individuals with Alcohol Use Disorders.

Gunn RL, Gerst KR, Wiemers EA, Redick TS, Finn PR.

Alcohol Clin Exp Res. 2018 Dec;42(12):2432-2441. doi: 10.1111/acer.13892. Epub 2018 Oct 25.

PMID:
30247753
18.

Evaluation of an Electronic Health Record (EHR) Tool for Integrated Behavioral Health in Primary Care.

Jetelina KK, Woodson TT, Gunn R, Muller B, Clark KD, DeVoe JE, Balasubramanian BA, Cohen DJ.

J Am Board Fam Med. 2018 Sep-Oct;31(5):712-723. doi: 10.3122/jabfm.2018.05.180041.

19.

Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging.

Whittington A, Gunn RN; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2019 Apr;60(4):536-540. doi: 10.2967/jnumed.118.210518. Epub 2018 Sep 6.

20.

Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.

21.

First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site.

Venkataraman AV, Keat N, Myers JF, Turton S, Mick I, Gunn RN, Rabiner EA, Passchier J, Parker CA, Tyacke RJ, Nutt DJ.

EJNMMI Res. 2018 Jul 30;8(1):71. doi: 10.1186/s13550-018-0429-x.

22.

Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.

Turton S, Myers JF, Mick I, Colasanti A, Venkataraman A, Durant C, Waldman A, Brailsford A, Parkin MC, Dawe G, Rabiner EA, Gunn RN, Lightman SL, Nutt DJ, Lingford-Hughes A.

Mol Psychiatry. 2018 Jun 25. doi: 10.1038/s41380-018-0107-4. [Epub ahead of print]

23.

Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

O'Leary TP, Hussin AT, Gunn RK, Brown RE.

Brain Res Bull. 2018 Jun;140:347-354. doi: 10.1016/j.brainresbull.2018.05.021. Epub 2018 Jun 2.

PMID:
29870778
24.

Brain lesion segmentation through image synthesis and outlier detection.

Bowles C, Qin C, Guerrero R, Gunn R, Hammers A, Dickie DA, Valdés Hernández M, Wardlaw J, Rueckert D.

Neuroimage Clin. 2017 Sep 8;16:643-658. doi: 10.1016/j.nicl.2017.09.003. eCollection 2017.

25.

Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems.

Gunn RL, Jackson KM, Borsari B, Metrik J.

Borderline Personal Disord Emot Dysregul. 2018 May 16;5:10. doi: 10.1186/s40479-018-0087-7. eCollection 2018.

26.

Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects.

Paul S, Gallagher E, Liow JS, Mabins S, Henry K, Zoghbi SS, Gunn RN, Kreisl WC, Richards EM, Zanotti-Fregonara P, Morse CL, Hong J, Kowalski A, Pike VW, Innis RB, Fujita M.

J Cereb Blood Flow Metab. 2019 Jun;39(6):1138-1147. doi: 10.1177/0271678X18771250. Epub 2018 May 11.

PMID:
29749279
27.

Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders.

Metrik J, Gunn RL, Jackson KM, Sokolovsky AW, Borsari B.

Alcohol Clin Exp Res. 2018 Jun;42(6):1096-1104. doi: 10.1111/acer.13639. Epub 2018 May 8.

28.

Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.

Mc Ardle R, Morris R, Hickey A, Del Din S, Koychev I, Gunn RN, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Zetterberg H, MacKay C, Lovestone S, Rochesteron L; Deep and Frequent Phenotyping study team (.

J Alzheimers Dis. 2018;63(1):331-341. doi: 10.3233/JAD-171116. Erratum in: J Alzheimers Dis. 2018;63(4):1557.

PMID:
29614664
29.

VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies.

Gunn RJ, Herrin BR, Acharya S, Cooper MD, Wilson IA.

J Mol Biol. 2018 Apr 27;430(9):1350-1367. doi: 10.1016/j.jmb.2018.03.016. Epub 2018 Mar 26.

30.

Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human Brain.

Tyacke RJ, Myers JFM, Venkataraman A, Mick I, Turton S, Passchier J, Husbands SM, Rabiner EA, Gunn RN, Murphy PS, Parker CA, Nutt DJ.

J Nucl Med. 2018 Oct;59(10):1597-1602. doi: 10.2967/jnumed.118.208009. Epub 2018 Mar 9.

31.

Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.

Firouzian A, Whittington A, Searle GE, Koychev I, Zamboni G, Lovestone S, Gunn RN; Deep and Frequent Phenotyping study team.

EJNMMI Res. 2018 Mar 2;8(1):19. doi: 10.1186/s13550-018-0371-y.

32.

A guide to manufacturing CAR T cell therapies.

Vormittag P, Gunn R, Ghorashian S, Veraitch FS.

Curr Opin Biotechnol. 2018 Oct;53:164-181. doi: 10.1016/j.copbio.2018.01.025. Epub 2018 Feb 18. Review.

PMID:
29462761
33.

A qualitative study of patient experiences of care in integrated behavioral health and primary care settings: more similar than different.

Davis MM, Gunn R, Gowen LK, Miller BF, Green LA, Cohen DJ.

Transl Behav Med. 2018 Sep 8;8(5):649-659. doi: 10.1093/tbm/ibx001.

PMID:
29425354
34.

Translocator Protein as an Imaging Marker of Macrophage and Stromal Activation in Rheumatoid Arthritis Pannus.

Narayan N, Owen DR, Mandhair H, Smyth E, Carlucci F, Saleem A, Gunn RN, Rabiner EA, Wells L, Dakin SG, Sabokbar A, Taylor PC.

J Nucl Med. 2018 Jul;59(7):1125-1132. doi: 10.2967/jnumed.117.202200. Epub 2018 Jan 4.

35.

The effects of working memory load and attention refocusing on delay discounting rates in alcohol use disorder with comorbid antisocial personality disorder.

Gunn RL, Gerst KR, Lake AJ, Finn PR.

Alcohol. 2018 Feb;66:9-14. doi: 10.1016/j.alcohol.2017.07.009. Epub 2017 Sep 23.

36.

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.

Scott G, Zetterberg H, Jolly A, Cole JH, De Simoni S, Jenkins PO, Feeney C, Owen DR, Lingford-Hughes A, Howes O, Patel MC, Goldstone AP, Gunn RN, Blennow K, Matthews PM, Sharp DJ.

Brain. 2018 Feb 1;141(2):459-471. doi: 10.1093/brain/awx339.

37.

Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities.

Whittington A, Sharp DJ, Gunn RN; Alzheimer’s Disease Neuroimaging Initiative.

J Nucl Med. 2018 May;59(5):822-827. doi: 10.2967/jnumed.117.194720. Epub 2017 Nov 16.

38.

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.

Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.

Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.

39.

Sex-related marijuana expectancies as predictors of sexual risk behavior following smoked marijuana challenge.

Skalski LM, Gunn RL, Caswell A, Maisto S, Metrik J.

Exp Clin Psychopharmacol. 2017 Oct;25(5):402-411. doi: 10.1037/pha0000138.

40.

Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios.

Fujita M, Kobayashi M, Ikawa M, Gunn RN, Rabiner EA, Owen DR, Zoghbi SS, Haskali MB, Telu S, Pike VW, Innis RB.

EJNMMI Res. 2017 Oct 16;7(1):84. doi: 10.1186/s13550-017-0334-8.

41.

Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates.

Collins BC, Gunn RJ, McKitrick TR, Cummings RD, Cooper MD, Herrin BR, Wilson IA.

Structure. 2017 Nov 7;25(11):1667-1678.e4. doi: 10.1016/j.str.2017.09.003. Epub 2017 Oct 5.

42.

Thermal Imaging Is a Noninvasive Alternative to PET/CT for Measurement of Brown Adipose Tissue Activity in Humans.

Law J, Morris DE, Izzi-Engbeaya C, Salem V, Coello C, Robinson L, Jayasinghe M, Scott R, Gunn R, Rabiner E, Tan T, Dhillo WS, Bloom S, Budge H, Symonds ME.

J Nucl Med. 2018 Mar;59(3):516-522. doi: 10.2967/jnumed.117.190546. Epub 2017 Sep 14.

43.

PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.

Koychev I, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard R, Zetterberg H, MacKay C, Lovestone S; Deep and Frequent Phenotyping study team (.

J Alzheimers Dis. 2017;60(1):283-293. doi: 10.3233/JAD-170129. Erratum in: J Alzheimers Dis. 2018;63(1):407.

44.

Delay Discounting of Losses in Alcohol Use Disorders and Antisocial Psychopathology: Effects of a Working Memory Load.

Gerst KR, Gunn RL, Finn PR.

Alcohol Clin Exp Res. 2017 Oct;41(10):1768-1774. doi: 10.1111/acer.13472. Epub 2017 Sep 8.

45.

Quantification of human brain PDE4 occupancy by GSK356278: A [11C](R)-rolipram PET study.

van der Aart J, Salinas C, Dimber R, Pampols-Maso S, Weekes AA, Tonkyn J, Gray FA, Passchier J, Gunn RN, Rabiner EA.

J Cereb Blood Flow Metab. 2018 Nov;38(11):2033-2040. doi: 10.1177/0271678X17720868. Epub 2017 Jul 24.

46.

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.

Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Neurology. 2017 Aug 8;89(6):586-593. doi: 10.1212/WNL.0000000000004201. Epub 2017 Jul 12.

PMID:
28701494
47.

Expectancy of impairment attenuates marijuana-induced risk taking.

Gunn RL, Skalski L, Metrik J.

Drug Alcohol Depend. 2017 Sep 1;178:39-42. doi: 10.1016/j.drugalcdep.2017.04.027. Epub 2017 Jun 13.

48.

Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation.

Coello C, Fisk M, Mohan D, Wilson FJ, Brown AP, Polkey MI, Wilkinson I, Tal-Singer R, Murphy PS, Cheriyan J, Gunn RN.

EJNMMI Res. 2017 Dec;7(1):47. doi: 10.1186/s13550-017-0291-2. Epub 2017 May 25.

49.

Outcomes of Integrated Behavioral Health with Primary Care.

Balasubramanian BA, Cohen DJ, Jetelina KK, Dickinson LM, Davis M, Gunn R, Gowen K, deGruy FV 3rd, Miller BF, Green LA.

J Am Board Fam Med. 2017 Mar-Apr;30(2):130-139. doi: 10.3122/jabfm.2017.02.160234.

50.

Estimating the implicit component of visuomotor rotation learning by constraining movement preparation time.

Leow LA, Gunn R, Marinovic W, Carroll TJ.

J Neurophysiol. 2017 Aug 1;118(2):666-676. doi: 10.1152/jn.00834.2016. Epub 2017 Mar 29.

Supplemental Content

Support Center